Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  USANA Health Sciences, Inc.    USNA

USANA HEALTH SCIENCES, INC. (USNA)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
04/17/2018 04/18/2018 04/19/2018 04/20/2018 04/23/2018 Date
99.45(c) 100(c) 99.65(c) 100.35(c) 97.4 Last
122 207 147 863 113 922 104 269 164 361 Volume
+1.12% +0.55% -0.35% +0.70% -2.94% Change
More quotes
Financials (USD)
Sales 2018 1 133 M
EBIT 2018 156 M
Net income 2018 106 M
Finance 2018 326 M
Yield 2018 -
Sales 2019 1 207 M
EBIT 2019 169 M
Net income 2019 116 M
Finance 2019 419 M
Yield 2019 -
P/E ratio 2018 22,82
P/E ratio 2019 20,02
EV / Sales2018 1,84x
EV / Sales2019 1,65x
Capitalization 2 415 M
More Financials
Company
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products.Its product line divided into four categories: Essentials, Optimizers, Foods, and Sense-beautiful science.The Essentials Nutritionals category includes vitamin and mineral supplements... 
Sector
Personal Products
Calendar
04/24Earnings Release
More about the company
Latest news on USANA HEALTH SCIENCES, INC
04/06USANA HEALTH SCIENCES : Schedules First Quarter Earnings Release and Conference ..
BU
04/02USANA HEALTH SCIENCES : Global Leader in Nutrition Expanding to Four New Markets
PR
03/26USANA HEALTH SCIENCES : Developments in the Direct Selling Industry
PR
03/12USANA : Named Top Rated Direct Selling Brand for Fifth Time
PR
02/28USANA HEALTH SCIENCES : Management's Discussion and Analysis of Financial Condit..
AQ
02/15USANA HEALTH SCIENCES : Reports Record Fourth Quarter and Full-Year 2017 Net Sal..
AQ
02/07USANA HEALTH SCIENCES : reports 4Q loss
AQ
02/06USANA HEALTH SCIENCES INC : Results of Operations and Financial Condition, Regul..
AQ
02/06USANA HEALTH SCIENCES : Reports Record Fourth Quarter and Full-Year 2017 Net Sal..
BU
02/05USANA HEALTH SCIENCES : Unleash Your Body's Age-Defying Power With Revolutionary..
PR
More news
Sector news : Personal Products - NEC
04/20Wall Street falls on investor nerves about interest rates, tech
RE
04/20P&G's vitamin boost could signal more to come
RE
04/20RECKITT BENCKISER : Foot-File Foray Trips Up Reckitt -- 2nd Update
DJ
04/20Reckitt Benckiser Shares Slide After 1Q Sales Miss Expectations -- Update
DJ
04/20Reckitt Benckiser Says 1Q Revenue Rose, Backs Full-Year Guidance
DJ
More sector news : Personal Products - NEC
4-Traders Strategies on USANA HEALTH SCIENCES, INC 
USANA HEALTH SCIENCES - 2015
Severely penalized
BUY
USANA HEALTH SCIENCES - 2015
Offers a growth potential
BUY
More Strategies
Latest Tweets
12:11pFinancial Comparison: Foamix Pharmaceuticals $FOMX & USANA Health Science.. 
04/22USANA Health Sciences $USNA Sets New 12-Month High and Low at $100.45  
04/22USANA Health Sciences $USNA Reaches New 1-Year High and Low at $100.45  
04/22Reviewing USANA Health Sciences $USNA and ChromaDex $CDXC  
04/21USANA Health Sciences $USNA and True Drinks $TRUU Head-To-Head Survey  
More tweets
Qtime:265
News from SeekingAlpha
02/20DAILY INSIDER RATINGS ROUND UP 2/16/ : Mli, odt, rarx, snap, ston, wair 
02/19BY THE NUMBERS : Cheap Stocks With Solid Fundamentals 
02/07USANA Health Sciences' (USNA) Q4 2017 Results - Earnings Call Transcript 
02/06USANA Q4 sales down 7%; non-GAAP earnings down 19% 
02/06USANA Health Sciences beats by $0.11, beats on revenue 
Chart USANA HEALTH SCIENCES, INC
Duration : Period :
USANA Health Sciences, Inc Technical Analysis Chart | USNA | US90328M1071 | 4-Traders
Technical analysis trends USANA HEALTH SCIENCES, INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 95,7 $
Spread / Average Target -4,7%
EPS Revisions
Managers
NameTitle
Kevin G. Guest Chief Executive Officer & Director
Jim Brown President & Chief Operating Officer
Myron W. Wentz Chairman
G. Douglas Hekking Chief Financial Officer
Robert Andrew Sinnott Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
USANA HEALTH SCIENCES, INC.35.52%2 415
PROCTER & GAMBLE COMPANY-19.68%186 050
UNILEVER NV (ADR)-1.83%162 999
UNILEVER (NL)-3.62%162 239
UNILEVER-6.13%162 239
COLGATE-PALMOLIVE COMPANY-7.53%58 974